Intradigm Corporation
6Patents
5Active
6Granted
42Portfolio score
Filing activity: Apr 1, 2004 → Apr 9, 2009 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7534878B2 | Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases | Chemistry; Metallurgy | 10 | Active |
| US7893244B2 | Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases | Human Necessities | 5 | Active |
| US7786092B2 | Composition and method of RNAi therapeutics for treatment of cancer and other neovascularization diseases | Chemistry; Metallurgy | 5 | Active |
| US7723316B2 | Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases | Chemistry; Metallurgy | 4 | Active |
| US7893243B2 | Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases | Chemistry; Metallurgy | 2 | Active |
| US7781414B2 | Targets for tumor growth inhibition | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.